Amarantus Bioscience Holdings Inc AMBS
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.25
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 630.41M
- Market Cap
- $630.41
- Volume/Avg
- 50,001 / 251,757
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Amarantus Bioscience Holdings Inc is a biopharmaceutical company. It is focused on developing therapeutic products for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company's prime therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia. The group's diagnostics division is dedicated to the development and commercialization of neurology diagnostic products. Its diagnostic product, LymPro Test is a blood-based assay to diagnose Alzheimer's disease.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 12
- Website
- —
Valuation
|
Metric
|
AMBS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AMBS
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.03 |
Interest Coverage | −4.84 |
Quick Ratio
AMBS
Profitability
|
Metric
|
AMBS
|
|---|---|
Return on Assets (Normalized) | −188.60% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|$^tQ@H | LOCK|@&W< | $126B | |||
| Moderna Inc
MRNA
| LOCK|XlcSh& | LOCK|#< | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|X&kWsT | LOCK|mB&&q | $80B | |||
| argenx SE ADR
ARGX
| LOCK|LVknW&h | LOCK|##@ | $53B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|mZhzj^ | LOCK|f&J | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|Q>&#Fw | LOCK|&pC>& | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|^?Y!G$h! | LOCK|GQJs | $26B | |||
| Incyte Corp
INCY
| LOCK|xdPLWQG | LOCK|!L? | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|l&f!ZLK | LOCK|r& | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|#>V<gqd | LOCK|Y#t | $14B |
United States